Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial — M. Ikeda (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
Shared by
Masatoshi Kudo
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
Article
2016
en
Authors
+15 more
MI
M. Ikeda
SS
Satoshi Shimizu
TS
Tosiya Sato
Abstract
1 min read
UMIN-CTR (http://www.umin.ac.jp/ctr/index-j.htm), identification number: UMIN000005703.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2015
Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial.
Masafumi Ikeda
,
Satoshi Shimizu
,
Tosiya Sato
,
Manabu Morimoto
,
Yoshitaka Inaba
,
Yasushi Kojima
,
Atsushi Hagihara
,
Masatoshi Kudo
,
Shoji Nakamori
,
Shuichi Kaneko
,
Rie Sugimoto
,
Toshiyuki Tahara
,
Takumi Ohmura
,
Kohichiroh Yasui
,
Keiko Sato
,
Hiroshi Ishii
,
Junji Furuse
,
Takuji Okusaka
Article
2023
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD
Masafumi Ikeda
,
Tatsuya Yamashita
,
Sadahisa Ogasawara
,
Masatoshi Kudo
,
Yoshitaka Inaba
,
Manabu Morimoto
,
Kaoru Tsuchiya
,
Satoshi Shimizu
,
Yasushi Kojima
,
Atsushi Hiraoka
,
Kazuhiro Nouso
,
Hiroshi Aikata
,
Kazushi Numata
,
Tosiya Sato
,
Takuji Okusaka
,
Junji Furuse
Article
2021
937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
Masafumi Ikeda
,
Tatsuya Yamashita
,
Sadahisa Ogasawara
,
Masatoshi Kudo
,
Yoshitaka Inaba
,
Manabu Morimoto
,
Kaoru Tsuchiya
,
Shinichi Shimizu
,
Yasushi Kojima
,
Atsushi Hiraoka
,
Kazuhiro Nouso
,
Hiroshi Aikata
,
Kazushi Numata
,
Tosiya Sato
,
Takuji Okusaka
,
Junji Furuse
Article
2020
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Kazuomi Ueshima
,
Sadahisa Ogasawara
,
Masafumi Ikeda
,
Yutaka Yasui
,
Takeshi Terashima
,
Tatsuya Yamashita
,
Shuntaro Obi
,
Shinpei Sato
,
Hiroshi Aikata
,
Takumi Ohmura
,
Hidekatsu Kuroda
,
Takamasa Ohki
,
Kengo Nagashima
,
Yoshihiko Ooka
,
Masahiro Takita
,
Masayuki Kurosaki
,
Kazuaki Chayama
,
Shuichi Kaneko
,
Namiki Izumi
,
Naoya Kato
,
Masatoshi Kudo
,
Masao Omata
Dataset
Supplementary Material for: Multicenter Phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD
Masafumi Ikeda
,
Tatsuya Yamashita
,
Sadahisa Ogasawara
,
Masatoshi Kudo
,
Yoshitaka Inaba
,
Manabu Morimoto
,
Kaoru Tsuchiya
,
Shinichi Shimizu
,
Yasushi Kojima
,
Atsushi Hiraoka
,
Kazuhiro Nouso
,
Hiroshi Aikata
,
Kazushi Numata
,
Tosiya Sato
,
Takuji Okusaka
,
Junji Furuse
Discussion(0)
No comments yet. Be the first to comment.